top of page

Topic

Bladder Cancer

65 Podcasts • 4 Courses on BackTable

Hear how experienced physicians manage Bladder Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 320  •  31 Jul 2026

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive

Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Ruchi Talwar interviews Dr. Sarah Psutka to explore the emerging role of a novel intravesical device that delivers sustained gemcitabine therapy for patients refusing or ineligible for cystectomy. They highlight new FDA-approved treatment options, real-world workflow considerations, and the clinical potential for continuous intravesical chemotherapy in a crowded therapeutic landscape.

This podcast is supported by

Johnson & Johnson

More on Bladder Cancer

Loading recent podcasts…

Urology

Urology # 320

Jul 31, 2026

with Dr. Sarah Psutka, Dr. Ruchika Talwar

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive

Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder...

Urology

Urology # 313

Jun 30, 2026

with Dr. Kirsten Greene, Dr. Ruchika Talwar

Approaches to Pelvic Lymph Node Dissection in Contemporary Prostate Cancer Surgery

Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology,...

970+ listens

Tumor Board

Tumor Board # 69

Jun 25, 2026

with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam

Managing Intravesical Therapy Toxicities in Bladder Cancer

How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...

100+ listens

Urology

Urology # 310

Jun 18, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

970+ listens

Urology

Urology # 316

Jul 14, 2026

with Dr. Adam Gadzinski, Dr. Ruchika Talwar

Bladder Cancer in the Community: Meeting Patients Where They Are

As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this...

20+ listens

Urology

Urology # 312

Jun 25, 2026

with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam

Managing Intravesical Therapy Toxicities in Bladder Cancer

How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...

830+ listens

Tumor Board

Tumor Board # 67

Jun 18, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

30+ listens

Urology

Urology # 308

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

940+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page